Free Trial

Shuttle Pharmaceuticals (SHPH) Competitors

Shuttle Pharmaceuticals logo
$0.28 +0.01 (+5.16%)
Closing price 04:00 PM Eastern
Extended Trading
$0.29 +0.01 (+2.06%)
As of 04:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SHPH vs. NKGN, PTN, LIPO, BCLI, FRTX, GTBP, GNPX, ALBT, NLSP, and SNGX

Should you be buying Shuttle Pharmaceuticals stock or one of its competitors? The main competitors of Shuttle Pharmaceuticals include NKGen Biotech (NKGN), Palatin Technologies (PTN), Lipella Pharmaceuticals (LIPO), Brainstorm Cell Therapeutics (BCLI), Fresh Tracks Therapeutics (FRTX), GT Biopharma (GTBP), Genprex (GNPX), Avalon GloboCare (ALBT), NLS Pharmaceutics (NLSP), and Soligenix (SNGX). These companies are all part of the "pharmaceutical products" industry.

Shuttle Pharmaceuticals vs.

Shuttle Pharmaceuticals (NASDAQ:SHPH) and NKGen Biotech (NYSE:NKGN) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, community ranking, media sentiment, institutional ownership, profitability and dividends.

In the previous week, Shuttle Pharmaceuticals had 2 more articles in the media than NKGen Biotech. MarketBeat recorded 2 mentions for Shuttle Pharmaceuticals and 0 mentions for NKGen Biotech. Shuttle Pharmaceuticals' average media sentiment score of 0.43 beat NKGen Biotech's score of 0.00 indicating that Shuttle Pharmaceuticals is being referred to more favorably in the media.

Company Overall Sentiment
Shuttle Pharmaceuticals Neutral
NKGen Biotech Neutral

Shuttle Pharmaceuticals has a beta of -1.04, suggesting that its share price is 204% less volatile than the S&P 500. Comparatively, NKGen Biotech has a beta of 0.83, suggesting that its share price is 17% less volatile than the S&P 500.

Shuttle Pharmaceuticals has higher earnings, but lower revenue than NKGen Biotech. Shuttle Pharmaceuticals is trading at a lower price-to-earnings ratio than NKGen Biotech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Shuttle PharmaceuticalsN/AN/A-$6.59M-$4.15-0.07
NKGen Biotech$80K74.95-$82.94M-$2.45-0.05

Shuttle Pharmaceuticals and NKGen Biotech both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Shuttle PharmaceuticalsN/AN/A
NKGen BiotechN/AN/A

4.6% of Shuttle Pharmaceuticals shares are held by institutional investors. Comparatively, 76.2% of NKGen Biotech shares are held by institutional investors. 12.6% of Shuttle Pharmaceuticals shares are held by insiders. Comparatively, 10.4% of NKGen Biotech shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

NKGen Biotech's return on equity of 0.00% beat Shuttle Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Shuttle PharmaceuticalsN/A -583.02% -258.92%
NKGen Biotech N/A N/A -479.36%

Summary

NKGen Biotech beats Shuttle Pharmaceuticals on 6 of the 11 factors compared between the two stocks.

Get Shuttle Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for SHPH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SHPH vs. The Competition

MetricShuttle PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$1.76M$6.71B$5.49B$7.95B
Dividend YieldN/A3.05%5.11%4.22%
P/E Ratio-0.077.3522.6218.58
Price / SalesN/A241.98397.85103.49
Price / CashN/A65.8538.1834.62
Price / Book0.146.496.744.25
Net Income-$6.59M$143.41M$3.22B$248.18M
7 Day Performance-5.19%2.24%1.59%1.36%
1 Month Performance-31.03%7.16%4.09%3.85%
1 Year PerformanceN/A-2.45%15.98%5.37%

Shuttle Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SHPH
Shuttle Pharmaceuticals
0.6283 of 5 stars
$0.28
+5.2%
N/AN/A$1.76MN/A-0.075Gap Up
NKGN
NKGen Biotech
N/A$0.14
+5.9%
N/A-89.1%$6.07M$80,000.00-0.03N/AGap Down
PTN
Palatin Technologies
N/A$0.23
+5.0%
N/AN/A$6.01M$350,000.00-0.1530News Coverage
Gap Down
LIPO
Lipella Pharmaceuticals
2.4561 of 5 stars
$2.28
-5.0%
N/A-57.3%$5.81M$536,357.00-0.544Upcoming Earnings
BCLI
Brainstorm Cell Therapeutics
3.7009 of 5 stars
$0.86
-1.8%
$30.00
+3,388.4%
-77.0%$5.71MN/A-0.1840Short Interest ↑
Positive News
Gap Up
FRTX
Fresh Tracks Therapeutics
N/A$0.94
-0.5%
N/A+2.7%$5.59M$10.06M-0.6620
GTBP
GT Biopharma
3.5018 of 5 stars
$2.17
-4.4%
$11.00
+406.9%
-19.3%$5.50MN/A-0.318Short Interest ↓
Positive News
Gap Down
GNPX
Genprex
4.0101 of 5 stars
$0.23
-6.2%
$10.00
+4,342.5%
-87.2%$5.44MN/A0.0020News Coverage
Gap Down
ALBT
Avalon GloboCare
0.9525 of 5 stars
$3.23
-9.5%
N/A-9.3%$5.34M$1.31M-0.165Short Interest ↑
News Coverage
Gap Up
NLSP
NLS Pharmaceutics
N/A$1.45
-0.7%
N/A+953.7%$5.22MN/A0.006
SNGX
Soligenix
0.3113 of 5 stars
$2.07
-1.4%
N/A-68.4%$5.20M$840,000.00-0.2720News Coverage

Related Companies and Tools


This page (NASDAQ:SHPH) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners